Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Franklin Templeton is a global investment management firm with over $1.4 trillion in assets under management. It offers mutual funds and ETFs across various sectors—including healthcare and biotechnology through specific funds—but does not itself develop drugs or therapies. The "Franklin Biotechnology Discovery Fund" invests in biotechnology companies but this fund's performance reflects the sector rather than any proprietary clinical results from Franklin Templeton itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Franklin Templeton.